Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

The chimeric antigen receptor-modified immune effector cell (CAR-T and CAR-NK) therapies are newly developed adoptive treatments of cancers. However, their therapeutic efficacy against solid tumors is limited. Combining CAR-T or CAR-NK cells with chemotherapeutic drugs to treat solid tumor may be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Tian, Kang, Xu, Jinjing, Zhang, Haixu, Li, Liantao, Fu, Qiang, Chai, Dafei, Li, Huizhong, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750507/
https://www.ncbi.nlm.nih.gov/pubmed/29423418
http://dx.doi.org/10.1155/2017/6915912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750507/
https://www.ncbi.nlm.nih.gov/pubmed/29423418
http://dx.doi.org/10.1155/2017/6915912

Ejemplares similares